375 related articles for article (PubMed ID: 31208697)
1. Targeting the Tumor Microenvironment of Leukemia and Lymphoma.
Höpken UE; Rehm A
Trends Cancer; 2019 Jun; 5(6):351-364. PubMed ID: 31208697
[TBL] [Abstract][Full Text] [Related]
2. Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities.
Lu C; Rong D; Zhang B; Zheng W; Wang X; Chen Z; Tang W
Mol Cancer; 2019 Aug; 18(1):130. PubMed ID: 31464625
[TBL] [Abstract][Full Text] [Related]
3. Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
Darragh LB; Oweida AJ; Karam SD
Front Immunol; 2018; 9():3154. PubMed ID: 30766539
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.
Carnevalli LS; Ghadially H; Barry ST
Front Immunol; 2021; 12():633685. PubMed ID: 33953710
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model.
Nascimento C; Ferreira F
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188587. PubMed ID: 34237352
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
Front Immunol; 2020; 11():585214. PubMed ID: 33613512
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment.
Looi CK; Chung FF; Leong CO; Wong SF; Rosli R; Mai CW
J Exp Clin Cancer Res; 2019 Apr; 38(1):162. PubMed ID: 30987642
[TBL] [Abstract][Full Text] [Related]
8. Analysis of Spatial Organization of Suppressive Myeloid Cells and Effector T Cells in Colorectal Cancer-A Potential Tool for Discovering Prognostic Biomarkers in Clinical Research.
Zwing N; Failmezger H; Ooi CH; Hibar DP; Cañamero M; Gomes B; Gaire F; Korski K
Front Immunol; 2020; 11():550250. PubMed ID: 33193316
[TBL] [Abstract][Full Text] [Related]
9. Allies or Enemies-The Multifaceted Role of Myeloid Cells in the Tumor Microenvironment.
Haas L; Obenauf AC
Front Immunol; 2019; 10():2746. PubMed ID: 31849950
[TBL] [Abstract][Full Text] [Related]
10. Tumor-reactive immune cells protect against metastatic tumor and induce immunoediting of indolent but not quiescent tumor cells.
Payne KK; Keim RC; Graham L; Idowu MO; Wan W; Wang XY; Toor AA; Bear HD; Manjili MH
J Leukoc Biol; 2016 Sep; 100(3):625-35. PubMed ID: 26928306
[TBL] [Abstract][Full Text] [Related]
11. mTOR at the Transmitting and Receiving Ends in Tumor Immunity.
Guri Y; Nordmann TM; Roszik J
Front Immunol; 2018; 9():578. PubMed ID: 29662490
[TBL] [Abstract][Full Text] [Related]
12. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Balta E; Wabnitz GH; Samstag Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
[TBL] [Abstract][Full Text] [Related]
13. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.
Xing Y; Ruan G; Ni H; Qin H; Chen S; Gu X; Shang J; Zhou Y; Tao X; Zheng L
Front Immunol; 2021; 12():624725. PubMed ID: 34084160
[TBL] [Abstract][Full Text] [Related]
14. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
Front Immunol; 2021; 12():656364. PubMed ID: 34122412
[TBL] [Abstract][Full Text] [Related]
15. Myeloid-derived suppressor cells and their role in pancreatic cancer.
Pergamo M; Miller G
Cancer Gene Ther; 2017 Mar; 24(3):100-105. PubMed ID: 27910857
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
Soongsathitanon J; Jamjuntra P; Sumransub N; Yangngam S; De la Fuente M; Landskron G; Thuwajit P; Hermoso MA; Thuwajit C
J Immunol Res; 2021; 2021():8840066. PubMed ID: 34337083
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer.
Vonderheide RH; Bear AS
Front Immunol; 2020; 11():605619. PubMed ID: 33304355
[TBL] [Abstract][Full Text] [Related]
18. A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment.
Liu YT; Tseng TC; Soong RS; Peng CY; Cheng YH; Huang SF; Chuang TH; Kao JH; Huang LR
J Immunother Cancer; 2018 Dec; 6(1):144. PubMed ID: 30526672
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells in lymphoma: The good, the bad and the ugly.
Betsch A; Rutgeerts O; Fevery S; Sprangers B; Verhoef G; Dierickx D; Beckers M
Blood Rev; 2018 Nov; 32(6):490-498. PubMed ID: 29691090
[TBL] [Abstract][Full Text] [Related]
20. Progress in the Understanding of the Immune Microenvironment and Immunotherapy in Malignant Pleural Mesothelioma.
Cheng L; Li N; Xu XL; Mao WM
Curr Drug Targets; 2020; 21(15):1606-1612. PubMed ID: 32682370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
